InteloMed, Inc. Announces Engagement of Investment Banking Firm Healthios Capital Markets, LLC as Exclusive Financial Advisor for Regulation D Private Placement
New Funding to Expand Commercialization of the InteloMed CVInsight(R) Patient Monitoring & Informatics System
(firmenpresse) - PITTSBURGH, PA -- (Marketwired) -- 09/06/16 -- ("InteloMed"), an emerging leader and developer of advanced non-invasive systems for patient monitoring and informatics, announced today that it has retained Healthios Capital Markets, LLC ("Healthios"), a premier investment bank focused on the global healthcare industry, as its exclusive financial advisor in connection with a Regulation D Private Placement.
"InteloMed is excited to partner with Healthios, an investment bank with unique expertise in the field of healthcare funding and a history of successful transactions," said InteloMed CEO Jill Schiaparelli. "We look forward to working with Healthios to help us grow InteloMed and empower clinical decision-making with advanced non-invasive monitoring and informatics solutions."
InteloMed is redefining the standard of care in patient monitoring and informatics through its CVInsight® Patient Monitoring & Informatics System, a non-invasive advanced monitoring system. It empowers clinicians with real-time, dynamic, and actionable information about a patient's cardiovascular stress level. Based on patented and proprietary algorithms, the system provides clinician-set alerts in response to changes in the patient's tolerance to illness, treatment and trauma, allowing them to provide immediate and appropriate interventions. The CVInsight® System can be used across a variety of healthcare settings and is FDA-cleared and CE-marked. The system has launched commercially in the US with initial focus in the dialysis market.
InteloMed is headquartered in Wexford, PA. For more information, visit us at .
Healthios Capital Markets, LLC, founded in 2005 and based in Northbrook, IL, offers strategic advisory and investment banking services to emerging growth healthcare companies.
** News, Media, PR and Content distribution provided by
Michael Dignazio
CFO
412.536.7654
Christoph Brandenberger
Managing Director
847.849.1739
(Investors with accredited status only)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.09.2016 - 12:00 Uhr
Sprache: Deutsch
News-ID 492822
Anzahl Zeichen: 0
contact information:
Town:
PITTSBURGH, PA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 149 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"InteloMed, Inc. Announces Engagement of Investment Banking Firm Healthios Capital Markets, LLC as Exclusive Financial Advisor for Regulation D Private Placement"
steht unter der journalistisch-redaktionellen Verantwortung von
InteloMed, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
